Company: RCUS
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0001724521-25-000040
Chunk: 66

Company: Arcus Biosciences, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 16
Chunk 66
---
 Ltd.  S-1333-22308610.12February 16, 201810.30BAmendment No. 1 to Option and License Agreement, dated September 19, 2017, between Arcus Biosciences, Inc. and Taiho Pharmaceutical Co, Ltd.10-Q001-3841910.1November 8, 201810.31CMemorandum, dated July 27, 2023, between Arcus Biosciences, Inc. and Taiho Pharmaceutical Co., LTD.10-Q001-3841910.1November 7, 2023

112

10.32COption, License and Collaboration Agreement dated May 27, 2020 between Arcus Biosciences, Inc. and Gilead Sciences, Inc.10-Q001-3841910.1August 6, 202010.33CAmendment No. 1 to the Option, License and Collaboration Agreement between Arcus Biosciences, Inc. and Gilead Sciences, Inc., dated November 17, 2021 10-K001-3841910.34February 23, 202210.34CAmendment No. 2 to the Option, License and Collaboration Agreement between Arcus Biosciences, Inc. and Gilead Sciences, Inc., dated May 15, 2023.10-Q001-3841910.1August 7, 202310.35CAmendment No. 3 to the Option, License and Collaboration Agreement between Arcus Biosciences, Inc. and Gilead Sciences, Inc., dated January 29, 2024.10-Q001-3841910.1May 8, 202410.36CAmendment No. 4 to the Option, License and Collaboration Agreement between Arcus Biosciences, Inc. and Gilead Sciences, Inc., dated May 10, 2024.10-Q001-3841910.1August 8, 202410.37CLetter Agreement with Gilead Sciences, Inc., dated July 1, 2022.10-Q001-3841910.2August 3, 202210.38CThird Amended and Restated Common Stock Purchase Agreement, dated January 29, 2024 between Arcus Biosciences, Inc. and Gilead Sciences, Inc. SC 13D/A005-9042399.1January 31, 202